Prime Medicine (PRME) director receives 75,000-share stock option grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Prime Medicine director Kelly Michael Aaron received a new stock option grant that could convert into common shares in the future. The award covers 75,000 shares of common stock at an exercise price of $3.06 per share and expires on June 5, 2036. According to the terms, the option vests in full on the earlier of June 5, 2027 or the date of Prime Medicine’s next annual stockholder meeting, as long as Aaron continues serving the company through that vesting date. After this grant, Aaron holds stock options for 75,000 underlying shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Kelly Michael Aaron
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 75,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 75,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 75,000 shares
Exercise price: $3.06 per share
Expiration date: June 5, 2036
+2 more
5 metrics
Option grant size
75,000 shares
Underlying common stock in new option award
Exercise price
$3.06 per share
Strike price for the stock option
Expiration date
June 5, 2036
Option term end date
Vesting latest date
June 5, 2027
Latest possible full vesting date, subject to service
Shares after transaction
75,000 options
Total options held following this grant
Key Terms
Stock Option (right to buy), exercise price, expiration date, vest in full, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 3.0600"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-05T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vest in full financial
"The shares subject to this option shall vest in full upon the earlier of"
annual meeting of stockholders financial
"the date of the next annual meeting of stockholders"
FAQ
What did Prime Medicine (PRME) director Kelly Michael Aaron report in this Form 4?
Kelly Michael Aaron reported receiving a stock option grant for 75,000 underlying shares of Prime Medicine common stock. The option was granted at a $3.06 exercise price and represents compensation, not an open-market stock purchase or sale.
What is the exercise price and expiration date of Aaron’s PRME stock option?
The option has an exercise price of $3.06 per share and an expiration date of June 5, 2036. Aaron may choose to exercise it after vesting, subject to remaining within this option term and paying the exercise price.
When do Kelly Michael Aaron’s Prime Medicine options vest?
The options vest in full on the earlier of June 5, 2027 or the date of Prime Medicine’s next annual meeting of stockholders. Vesting requires Aaron to maintain continuous service with the company through the applicable vesting date.
How many Prime Medicine options does Aaron hold after this transaction?
Following this grant, Kelly Michael Aaron holds stock options representing 75,000 underlying shares of Prime Medicine common stock directly. This entire position comes from the newly awarded option reported in the Form 4 filing.